विवरण
A new phase 3 trial (MANEUVER) investigates pimicotinib, a highly selective CSF-1R inhibitor, for unresectable tenosynovial giant cell tumour (TGCT). Part 1 results show promising anti-tumor activity with a manageable safety profile. In this video, authors of the trial describe MANEUVER and explain what this could mean for TGCT patients. Read the full article at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02602-9/fulltext?dgcid=youtube_video_lancet_maneuver-2026 Visit The Lancet at https://www.thelancet.com/?dgcid=youtube_video_lancet_maneuver-2026 * * * Continue this conversation on social! Follow us today at… https://TheLancet.bsky.social/ https://Facebook.com/TheLancetMedicalJournal https://Instagram.com/TheLancetGroup https://LinkedIn.com/company/The-Lancet
आपको ये भी पसंद आ सकते हैं
- 1
एल्बमMelody Zheir
Melody Zheir · 6,267 प्ले
- 2
एल्बमWatergate
Cøncenträte · 7,984 प्ले
- 3
एल्बमDemo 2012
Truthseeker · 3,913 प्ले
- 4
एल्बमМ2-55
М2-55 · 5,174 प्ले
- 5
एल्बमPaidLifeDoe
PaidLifeDoe · 6,405 प्ले
- 6
एल्बमWatch Your Step
Zem · 3,091 प्ले
- 7
एल्बमU Po'Ure
Gibonni · 1,200 प्ले
- 8
एल्बमMbëguel
NAPALMA · 6,435 प्ले
- 9
एल्बमSTORY MODE vol 1
KING AN SKILLET · 4,502 प्ले
- 10
एल्बमSixOwe Bidnezz
FBT 6ix0 · 8,925 प्ले
- 11
एल्बमDrum! Drum! Drum!
Drum! Drum! Drum! · 174 प्ले
- 12
एल्बमThoughts of 3
3XStevie · 2,661 प्ले